Interactions of Methylene Blue with Human Disulfide Reductases and Their Orthologues fromPlasmodium falciparum
- 1 January 2008
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 52 (1) , 183-191
- https://doi.org/10.1128/aac.00773-07
Abstract
Methylene blue (MB) has experienced a renaissance mainly as a component of drug combinations against Plasmodium falciparum malaria. Here, we report biochemically relevant pharmacological data on MB such as rate constants for the uncatalyzed reaction of MB at pH 7.4 with cellular reductants like NAD(P)H (k = 4 M(-1) s(-1)), thioredoxins (k = 8.5 to 26 M(-1) s(-1)), dihydrolipoamide (k = 53 M(-1) s(-1)), and slowly reacting glutathione. As the disulfide reductases are prominent targets of MB, optical tests for enzymes reducing MB at the expense of NAD(P)H under aerobic conditions were developed. The product leucomethylene blue (leucoMB) is auto-oxidized back to MB at pH 7 but can be stabilized by enzymes at pH 5.0, which makes this colorless compound an interesting drug candidate. MB was found to be an inhibitor and/or a redox-cycling substrate of mammalian and P. falciparum disulfide reductases, with the kcat values ranging from 0.03 s(-1) to 10 s(-1) at 25 degrees C. Kinetic spectroscopy of mutagenized glutathione reductase indicates that MB reduction is conducted by enzyme-bound reduced flavin rather than by the active-site dithiol Cys58/Cys63. The enzyme-catalyzed reduction of MB and subsequent auto-oxidation of the product leucoMB mean that MB is a redox-cycling agent which produces H2O2 at the expense of O2 and of NAD(P)H in each cycle, turning the antioxidant disulfide reductases into pro-oxidant enzymes. This explains the terms subversive substrate or turncoat inhibitor for MB. The results are discussed in cell-pathological and clinical contexts.Keywords
This publication has 53 references indexed in Scilit:
- Dithiol Proteins as Guardians of the Intracellular Redox Milieu in Parasites: Old and New Drug Targets in Trypanosomes and Malaria‐Causing PlasmodiaAngewandte Chemie International Edition in English, 2005
- The human malaria parasite Plasmodium falciparum possesses two distinct dihydrolipoamide dehydrogenasesMolecular Microbiology, 2004
- Occupational MethaemoglobinaemiaToxicological Reviews, 2003
- Photobleaching of methylene blue sensitised by TiO2: an ambiguous system?Journal of Photochemistry and Photobiology A: Chemistry, 1999
- The Blue Bottle Experiment - Simple Demonstration of Self-OrganizationJournal of Chemical Education, 1998
- A crystallographic study of the glutathione binding site of glutathione reductase at 0.3‐nm resolutionEuropean Journal of Biochemistry, 1989
- The identity of diaphorase and lipoyl dehydrogenaseBiochimica et Biophysica Acta, 1960
- The chemotherapy of Plasmodium berghei. I. Resistance to drugsParasitology, 1953
- Studies on Oxidation-Reduction: VIII. Methylene BluePublic Health Reports (1896-1970), 1925
- THE OCCURRENCE OF GREEN OR BLUE URINE AND ITS MOST FREQUENT CAUSEThe Lancet, 1901